Bilski: the life sciences angle

Intellectual Asset Management
February 2010

The Supreme Court’s decision in Bilski v. Kappos will address patent-eligibility of business methods, a topic of considerable interest to the e-commerce and financial services industries. But it could reach beyond business methods to affect the life sciences; that is, technological methods that affect living organisms, including methods for identifying medical conditions, methods for treating patients and pharmaceutical methods. This article reviews the Bilski case and recent Supreme Court and Federal Circuit patent-eligibility jurisprudence to highlight possible ramifications of the Bilski decision.

View Attachment (PDF)